Concord Medical's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Concord Medical Services Holdings Limited (CCM)

Q1 2012 Earnings Call

May 22, 2012 08:00 am ET

Executives

Tony Tian – Investor Relations Manager

Jianyu Yang – Chairman of the Board and Chief Executive Officer

Adam J. Sun – Chief Financial Officer

Zheng Cheng – President and Chief Operating Officer; Director

Analysts

Christopher Lui – Morgan Stanley Asia Ltd.

Yale I. Jen – ROTH Capital Partners LLC

Sean Wu – JPMorgan Securities (Asia Pacific) Ltd.

Presentation

Operator

Hello and thank you for standing by for Concord Medical’s first quarter 2012 earnings conference call. At this time, all participants are in listen-only mode. After management’s prepared remarks, there will be a question-and-answer session. Today’s conference is being recorded. If you have any objections you may disconnect at this time.

I would now like to turn the meeting over to your host for today’s conference, Tony Tian, Investor Relations Manager of Concord Medical.

Tony Tian

Hello everyone and welcome to Concord Medical’s first quarter 2012 earnings conference call. Concord Medical’s earnings release was distributed earlier today and you can find a copy on our website as well as on newswire services.

Today, you will hear from Dr. Jianyu Yang, Concord Medical’s Chairman and Chief Executive Officer, and Mr. Adam Sun, Chief Financial Officer. After their prepared remarks, Dr. Yang and Mr. Sun will be available to answer your questions.

Before we continue, please note that the discussion today will contain forward-looking statements made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from our current expectations. Potential risks and uncertainties include but are not limited to those outlined in our public filings with the SEC. Concord Medical does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

If you liked this article you might like

New Tronox Chairman Faces Test at Coatings and Pigments Maker

Breaking a Market Standstill

Breaking a Market Standstill

Oversold Conditions For Concord Medical Services Holdings (CCM)

3 Health Care Stocks Under $10 to Trade for Breakouts

Deal or No Deal: 6 Undervalued Stocks Under 10 Dollars from Abroad